| CONTENTS |
| Bringing the Patient’s Voice to Nasal Drug Delivery Louise Righton, Global Market Development Manager 3M Health Care Limited |
| HDA – A New Pulmonary Drug Delivery Platform Can Provide for More Efficient and Safer Delivery Mr Peter Boonen, Managing Director Stirling Products Limited |
| SUPRAER: A New Class of Aerosol Delivery System for Biotherapeutics Dr Donovan B Yeates, Chief Executive Officer KAER Biotherapeutics |
| The Last Word in Assembly Solutions Just Got Even Better Jean-François Bauer, Head of Marketing & Business Development Mikron Automation |
| Pulmonary Drug Delivery – Simplified Dr Andrea Leone-Bay, Vice-President, Pharmaceutical Development Mr Chad Smutney, Senior Director, Device Technology Mr Joseph Kocinsky, Senior Vice-President, Pharmaceutical Technology Development MannKind Corporation |
| Laser Diffraction and Automated Imaging: Complementary Techniques for Dry-Powder Inhaler Development Dr Paul Kippax, Product Group Manager, Micrometrics Malvern Instruments Ltd |
| Versatility of the KHFA pMDI Valve Mr Sergio Monti, V.A.R.I. SpA Prof Glyn Taylor, i2c Pharmaceutical Services Mr David Howlett, PharmaDelivery Solutions Ltd V.A.R.I. SpA |
| Novel Advances in Rapid Manufacturing, Deployment, and Delivery of Intranasally Administered Drugs and Biologics Mr Timothy Sullivan, President & Chief Executive Officer Mystic Pharmaceuticals, Inc |